FLT-3阻害剤の抗増殖活性と選択性を,キメラ変換を標的としたタンパク質分解によって強化する
George M Burslem1, Jayoung Song1, Xin Chen2
1Department of Molecular, Cellular and Developmental Biology , Yale University , New Haven , Connecticut 06511 , United States.
Journal of the American Chemical Society
|November 15, 2018
まとめ
研究者は,急性骨髄性白血病におけるFLT-3 ITD変異体を分解する新しいタンパク質分解標的 (PROTAC) を開発した. このPROTACは強力な抗がん活動と in vivo 効果を示し,有望な治療戦略を提供している.
科学分野:
- 腫瘍学
- 分子生物学
- 生物化学
背景:
- FMSのようなチロシンキナーゼ3 (FLT-3) 変異は,急性骨髄性白血病 (AML) で一般的です.
- 既存のFLT3阻害剤は臨床効果が限られている.
- FLT-3の分解をターゲットにすることで 治療の可能性が生まれます
研究 の 目的:
- FLT-3変異体分解のためのタンパク質分解標的キメラ (PROTAC) の開発と評価.
- PROTACの有効性を評価する
- 抗白血病活性強化のメカニズムを調査する.
主な方法:
- クイザルチニブベースのPROTACの化学合成
- FLT-3 ITDの分解とキナーゼ抑制のインビトロ評価
- 細胞増殖とアポトーシス解析
- 関連するモデルでの in vivo 試験
主要な成果:
- PROTACは低ナノモラー濃度でFLT-3 ITD変異体を効率的に分解しました.
- PROTACは,抗増殖効果が優れ,抑制剤単独よりも多くのアポトーシスを誘発した.
- PROTACは標的外キナーゼ阻害の減少を示した.
- FLT-3 ITDの体内分解が達成されました.
結論:
- FLT-3 ITDのPROTAC媒介による分解は強力な抗白血病戦略である.
- このアプローチは,従来のFLT-3阻害剤の限界を克服します.
- FLT-3 ITDの劣化は非キナーゼ機能を標的とし,治療の可能性を高めます.
関連する概念動画
02:08Gene Conversion
10.6K
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
10.6K
02:08Gene Conversion
3.1K
3.1K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
630
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
630
01:22T Cell Activation and Clonal Selection
16.1K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.1K
01:11ortho–para-Directing Activators: –CH3, –OH, –NH2, –OCH3
7.5K
All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
7.5K
01:52Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K